Life Science Paradigm Challenge

Common migraine medications can trigger an epigenetic switch that actually causes more headaches if they are used too often.

April 29, 2026

Original Paper

Triptans reprogram Schwann cells to drive medication-overuse headache via β-glycan/TGF-β3 signaling

Chieca, M.; Marini, M.; Baragli, M.; Bellantoni, E.; Bonacchi, L.; De Cesaris, F.; Tassorelli, C.; De Icco, R.; Greco, R.; Timotei, L.; Pulli, B.; Spinelli, G.; Souza Monteiro de Araujo, D.; Papini, A.; De Siena, G.; Scuffi, I.; Ferroni, G.; Pivotto, G.; Magi, A.; Nassini, R.; De Logu, F.

bioRxiv · 10.64898/2026.04.24.720547

The Takeaway

Triptans are the go-to drugs for stopping migraine attacks, but overusing them often leads to a vicious cycle of chronic pain. This study found that the medicine forces certain cells in the nervous system to stay in a pro-inflammatory state. These Schwann cells begin sending out distress signals that keep the brain in a state of constant sensitivity. It provides the first clear biological proof for why the very medicine designed to help can become the source of the problem. For millions of chronic headache sufferers, this discovery identifies a specific protein pathway that could be targeted to break the cycle of medication overuse. It confirms that too much relief can physically reprogram your nerves to hurt.

From the abstract

Medication-overuse headache (MOH) is one of the leading causes of chronic daily headache worldwide and arises from the repeated use of acute anti-migraine medications, including triptans. However, the cellular substrates and intracellular pathways driving this paradoxical chronification remain unknown. Here, using Schwann cell-selective silencing of the 5-HT1B/D receptor, we observed that acute triptan administration counteracts CGRP-induced, endosome-confined cAMP accumulation, preventing the d